Fibromyalgia syndrome is a common chronic pain syndrome that is often assoc
iated with sleep disturbances characterized by subjective experience of non
-restorative sleep. The complaints of sleep disturbances are correlated wit
h polysomnographic features clear abnormalities in the continuity of sleep
as well as in the sleep architecture. Sleep-recording abnormalities are cha
racterized by a reduced sleep efficiency with increased number of awakening
s, a reduced amount of slow wave sleep and an abnormal alpha wave intrusion
in non rapid eye movement, termed alpha-delta sleep. These data were confi
rmed by spectral analysis of sleep showing an increased EEG power density i
n the higher frequency band and a reduced EEG power density in the lower fr
equency bands. Moreover, other microstructural aspects of sleep were modifi
ed with high frequency of arousals and alpha-K complex reported, both indic
ators of fragmented sleep. The fibromyalgia symptoms may relate to a non-re
storative sleep disorder associated with the alpha-EEG sleep anomalies. How
ever, alpha-EEG sleep anomaly is non-specific for fibrositis, also seen in
normal controls during stage 4 sleep deprivation. Moreover, fibromyalgia pa
tients may also experience primary sleep disorder such as sleep apnea or pe
riodic leg movements. The etiology of this common condition is incompletely
understood and the existence of a specific entity of fibromyalgia is still
a matter of debate. However, several studies have found abnormal brain met
abolism of substances such as serotonin implicated in sleep arousal and pai
n mechanisms and administration of tricyclic antidepressants and selective
serotonin reuptake inhibitors may be useful in fibromyalgia. Pain, poor sle
ep quality and anxiety may contribute to the clinical picture. Several fact
ors such as psychological, environmental, genetic factor, altered serotonin
metabolism and altered sleep physiology are involved in the pathogenesis o
f fibromyalgia. (C) 2001 Editions scientifiques el medicales Elsevier SAS.